# Correction: Tsoi et al. Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer. Life 2022, 12, 93

**Authors:** Ho Tsoi, Ling Shi, Man-Hong Leung, Ellen P. S. Man, Zi-Qing So, Wing-Lok Chan, Ui-Soon Khoo

PMC · DOI: 10.3390/life14081044 · 2024-08-22

## Full-text entities

- **Genes:** CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}, CXCR1 (C-X-C motif chemokine receptor 1) [NCBI Gene 3577] {aka C-C, C-C-CKR-1, CD128, CD181, CDw128a, CKR-1}
- **Diseases:** Breast Cancer (MESH:D001943)

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11355626/full.md

---
Source: https://tomesphere.com/paper/PMC11355626